Skip to main content

Clear Cut Magazine

India’s NFHS-6: Maternal, Child Health and Nutrition Show Steady Improvement Signalling Social Progress

The recently released National Family Health Survey-6 (NFHS-6, 2023-24) by the Union Health Ministry details concrete gains across the country in significant public health and social indicators. Conducted by the International Institute for Population Sciences (IIPS), Mumbai, the survey of approximately 6.79 lakh households across 715 districts provides district-level estimations on population, health, nutrition, and…

Read More

India’s Fight Against Malnutrition

Malnutrition remains one of the most important and persistent public health problems in India. It is estimated that undernutrition directly or indirectly contributed to more than 68% of under five deaths in the country. Its long-term effects of cognition impairment, lesser educational outcomes, lesser productivity in life and intergenerational poverty are a structural drag on…

Read More

Social Protection in India: Has the Safety Net Actually Expanded?

At 65.3% in 2026, up from 22% in 2016, India’s population covered by social protection schemes shows an almost three-fold increase over a decade – that’s the government’s interpretation based on the Sustainable Development Goals – National Indicator Framework (SDG-NIF) Progress Report by the Ministry of Statistics and Program Implementation (MoSPI) on the country’s 20th…

Read More

When the Surgeon’s Screen Gets Smarter, Who Benefits?

India’s prostate cancer surgeries are getting more precise. Whether patients can reach the operating table at all remains a separate, and far less technical, problem. As recently as 1990, the rate of prostate cancer was 11th in India, while today, according to the National Cancer Registry Programme, it is the third most common in the…

Read More

$11.75 Billion: How Sun Pharma’s Biggest-Ever Deal Rewrites Indian Pharma’s Global Ambitions

THE BIGGEST CHEQUE AN INDIAN DRUGMAKER HAS EVER WRITTEN Indian pharmaceutical companies have spent the better part of two decades quietly building global manufacturing reach, mostly through incremental capacity expansion and a steady drumbeat of mid-sized acquisitions. Sun Pharmaceutical Industries just broke entirely from that pattern. The company announced it will acquire New York-listed Organon…

Read More